Basic/Clinical Science Session
Nanodelivery in Organ Transplantation: Myth or Reality?
November 05, 2022 | 10:30 AM - 12:30 PM
Location: WF3 Tangerine, Orange County Convention Center‚ West Building
Session Description
This session brings together experts in the field to evaluate potential clinical applications of targeted delivery of therapeutics through the use of nanoparticles in kidney transplantation.
Nanodelivery has emerged as a promising method that increases efficacy and reduces adverse effects of therapeutic drugs. Nanoparticles can be tailored to target tissues through conjugation to ligands that bind cell-specific receptors. Nanotherapeutic strategies could be used in solid organ transplants during the interval between organ harvest from the donor and placement into the recipient.
Learning Objective(s)
- Discuss the challenges of achieving effective nanotherapeutic delivery with kidney transplantation
- Understand the clinical benefits of nanotherapeutic strategies
- Summarize present and future research about the targeted delivery of therapeutics
Learning Pathway(s)
- Kidney Transplantation
- Pharmacology
Moderators
- Daniel A. Heller, PhD
- Martina M. McGrath, MBChB, FASN
Presentations
- Lymphoid Targeted Immune Therapy in Transplantation
10:30 AM - 11:00 AM
Reza Abdi, MD
- Stabilization of Cell-Cell Junctions: Novel Approach for Combating Ischemia Reperfusion Injury
11:00 AM - 11:30 AM
Carl Atkinson, PhD
- Nanoparticle-Based Targeted Drug Delivery to Prevent Ischemia Reperfusion Injury in Kidney Transplantation
11:30 AM - 12:00 PM
Satish N. Nadig, MD, PhD
- Nanoparticle-Based Targeted Cellular Delivery in Transplantation
12:00 PM - 12:30 PM
Xun-Rong Luo, MD, PhD